Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature
• Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and d...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Chalah, Moussa A. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
4 |
|---|
| Übergeordnetes Werk: |
Enthalten in: New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR - Song, Chun-hui ELSEVIER, 2023, Burlington, Mass |
|---|---|
| Übergeordnetes Werk: |
volume:52 ; year:2018 ; pages:1-4 ; extent:4 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jocn.2018.03.024 |
|---|
| Katalog-ID: |
ELV043035914 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV043035914 | ||
| 003 | DE-627 | ||
| 005 | 20230624102030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180726s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jocn.2018.03.024 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000230A.pica |
| 035 | |a (DE-627)ELV043035914 | ||
| 035 | |a (ELSEVIER)S0967-5868(18)30223-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 540 |q VZ |
| 084 | |a 35.00 |2 bkl | ||
| 100 | 1 | |a Chalah, Moussa A. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature |
| 264 | 1 | |c 2018 | |
| 300 | |a 4 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment. | ||
| 650 | 7 | |a Multiple sclerosis |2 Elsevier | |
| 650 | 7 | |a Cognitive therapy |2 Elsevier | |
| 650 | 7 | |a Behavioral therapy |2 Elsevier | |
| 650 | 7 | |a CBT |2 Elsevier | |
| 650 | 7 | |a Fatigue |2 Elsevier | |
| 650 | 7 | |a Cognitive behavioral therapies |2 Elsevier | |
| 700 | 1 | |a Ayache, Samar S. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Harcourt |a Song, Chun-hui ELSEVIER |t New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |d 2023 |g Burlington, Mass |w (DE-627)ELV009125612 |
| 773 | 1 | 8 | |g volume:52 |g year:2018 |g pages:1-4 |g extent:4 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jocn.2018.03.024 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.00 |j Chemie: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 52 |j 2018 |h 1-4 |g 4 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m a c ma mac |
|---|---|
| matchkey_str |
chalahmoussaaayachesamars:2018----:ontvbhvoateaisnmlilslrssaiu |
| hierarchy_sort_str |
2018 |
| bklnumber |
35.00 |
| publishDate |
2018 |
| allfields |
10.1016/j.jocn.2018.03.024 doi GBV00000000000230A.pica (DE-627)ELV043035914 (ELSEVIER)S0967-5868(18)30223-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Chalah, Moussa A. verfasserin aut Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment. Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies Elsevier Ayache, Samar S. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:52 year:2018 pages:1-4 extent:4 https://doi.org/10.1016/j.jocn.2018.03.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 52 2018 1-4 4 045F 610 |
| spelling |
10.1016/j.jocn.2018.03.024 doi GBV00000000000230A.pica (DE-627)ELV043035914 (ELSEVIER)S0967-5868(18)30223-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Chalah, Moussa A. verfasserin aut Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment. Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies Elsevier Ayache, Samar S. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:52 year:2018 pages:1-4 extent:4 https://doi.org/10.1016/j.jocn.2018.03.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 52 2018 1-4 4 045F 610 |
| allfields_unstemmed |
10.1016/j.jocn.2018.03.024 doi GBV00000000000230A.pica (DE-627)ELV043035914 (ELSEVIER)S0967-5868(18)30223-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Chalah, Moussa A. verfasserin aut Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment. Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies Elsevier Ayache, Samar S. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:52 year:2018 pages:1-4 extent:4 https://doi.org/10.1016/j.jocn.2018.03.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 52 2018 1-4 4 045F 610 |
| allfieldsGer |
10.1016/j.jocn.2018.03.024 doi GBV00000000000230A.pica (DE-627)ELV043035914 (ELSEVIER)S0967-5868(18)30223-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Chalah, Moussa A. verfasserin aut Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment. Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies Elsevier Ayache, Samar S. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:52 year:2018 pages:1-4 extent:4 https://doi.org/10.1016/j.jocn.2018.03.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 52 2018 1-4 4 045F 610 |
| allfieldsSound |
10.1016/j.jocn.2018.03.024 doi GBV00000000000230A.pica (DE-627)ELV043035914 (ELSEVIER)S0967-5868(18)30223-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.00 bkl Chalah, Moussa A. verfasserin aut Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature 2018 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment. Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies Elsevier Ayache, Samar S. oth Enthalten in Harcourt Song, Chun-hui ELSEVIER New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR 2023 Burlington, Mass (DE-627)ELV009125612 volume:52 year:2018 pages:1-4 extent:4 https://doi.org/10.1016/j.jocn.2018.03.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ AR 52 2018 1-4 4 045F 610 |
| language |
English |
| source |
Enthalten in New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR Burlington, Mass volume:52 year:2018 pages:1-4 extent:4 |
| sourceStr |
Enthalten in New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR Burlington, Mass volume:52 year:2018 pages:1-4 extent:4 |
| format_phy_str_mv |
Article |
| bklname |
Chemie: Allgemeines |
| institution |
findex.gbv.de |
| topic_facet |
Multiple sclerosis Cognitive therapy Behavioral therapy CBT Fatigue Cognitive behavioral therapies |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
| authorswithroles_txt_mv |
Chalah, Moussa A. @@aut@@ Ayache, Samar S. @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV009125612 |
| dewey-sort |
3610 |
| id |
ELV043035914 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043035914</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624102030.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jocn.2018.03.024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000230A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043035914</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0967-5868(18)30223-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chalah, Moussa A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Multiple sclerosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cognitive therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Behavioral therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CBT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fatigue</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cognitive behavioral therapies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ayache, Samar S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Song, Chun-hui ELSEVIER</subfield><subfield code="t">New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR</subfield><subfield code="d">2023</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009125612</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:52</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:1-4</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jocn.2018.03.024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">52</subfield><subfield code="j">2018</subfield><subfield code="h">1-4</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Chalah, Moussa A. |
| spellingShingle |
Chalah, Moussa A. ddc 610 ddc 540 bkl 35.00 Elsevier Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature |
| authorStr |
Chalah, Moussa A. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009125612 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 540 VZ 35.00 bkl Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies Elsevier |
| topic |
ddc 610 ddc 540 bkl 35.00 Elsevier Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies |
| topic_unstemmed |
ddc 610 ddc 540 bkl 35.00 Elsevier Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies |
| topic_browse |
ddc 610 ddc 540 bkl 35.00 Elsevier Multiple sclerosis Elsevier Cognitive therapy Elsevier Behavioral therapy Elsevier CBT Elsevier Fatigue Elsevier Cognitive behavioral therapies |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s s a ss ssa |
| hierarchy_parent_title |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
| hierarchy_parent_id |
ELV009125612 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry |
| hierarchy_top_title |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV009125612 |
| title |
Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature |
| ctrlnum |
(DE-627)ELV043035914 (ELSEVIER)S0967-5868(18)30223-6 |
| title_full |
Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature |
| author_sort |
Chalah, Moussa A. |
| journal |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
| journalStr |
New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
1 |
| author_browse |
Chalah, Moussa A. |
| container_volume |
52 |
| physical |
4 |
| class |
610 610 DE-600 540 VZ 35.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Chalah, Moussa A. |
| doi_str_mv |
10.1016/j.jocn.2018.03.024 |
| dewey-full |
610 540 |
| title_sort |
cognitive behavioral therapies and multiple sclerosis fatigue: a review of literature |
| title_auth |
Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature |
| abstract |
• Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment. |
| abstractGer |
• Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment. |
| abstract_unstemmed |
• Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature |
| url |
https://doi.org/10.1016/j.jocn.2018.03.024 |
| remote_bool |
true |
| author2 |
Ayache, Samar S. |
| author2Str |
Ayache, Samar S. |
| ppnlink |
ELV009125612 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.jocn.2018.03.024 |
| up_date |
2024-07-06T17:45:22.386Z |
| _version_ |
1803852628504870912 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043035914</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624102030.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jocn.2018.03.024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000230A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043035914</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0967-5868(18)30223-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chalah, Moussa A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Fatigue is a frequent and debilitating symptom in multiple sclerosis (MS) • Pharmacological therapies have modest efficacy and numerous side effects. • Fourteen studies employed cognitive behavioral therapies (CBT) in MS fatigue. • CBT seem to have positive effects on MS fatigue. • The onset and duration of CBT effects merit further assessment.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Multiple sclerosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cognitive therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Behavioral therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CBT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fatigue</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cognitive behavioral therapies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ayache, Samar S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Song, Chun-hui ELSEVIER</subfield><subfield code="t">New trends of new psychoactive substances (NPS)-infused chocolate: Identification and quantification of trace level of NPS in complex matrix by GC-MS and NMR</subfield><subfield code="d">2023</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009125612</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:52</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:1-4</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jocn.2018.03.024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">52</subfield><subfield code="j">2018</subfield><subfield code="h">1-4</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4018097 |